Literature DB >> 24343426

Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma.

Ling-Fei Jia1, Su-Bi Wei, Ye-Hua Gan, Yong Guo, Kai Gong, Keith Mitchelson, Jing Cheng, Guang-Yan Yu.   

Abstract

MicroRNA miR-26a and long noncoding RNA (lncRNA) MEG3 gene have been independently reported to be tumor suppressor genes in various cancers, but neither has been previously associated with tongue squamous cell carcinoma (TSCC). We report here that miR-26a and lncRNA MEG3 gene expression were both strongly reduced in TSCC compared with levels in matched nonmalignant tissues, and combined low expression levels of both miR-26a and MEG3 emerged as an independent prognostic factor for poor clinical outcome in TSCC patients. Assays in the human TSCC cell lines SCC-15 and CAL27 showed that miR-26a targets the DNA methyltransferase 3B transcript and that its inhibition may result in the upregulation of MEG3, providing a plausible link between the observed reduction of miR-26a and MEG3 in TSCC tissue. Furthermore, the overexpression of miR-26a or MEG3 in SCC-15 and CAL27 cells inhibited cell proliferation and cell cycle progression, and promoted cell apoptosis. Considering the poor prognostic outcomes associated with reduced miR-26a and MEG3, our findings imply that these factors likely play important antitumor effects in TSCC pathogenesis. Furthermore, they represent potential prognostic biomarkers for stratification of TSCC patients.
© 2013 UICC.

Entities:  

Keywords:  DNMT3B; MEG3; lncRNA; miR-26a; squamous cell carcinoma

Mesh:

Substances:

Year:  2014        PMID: 24343426     DOI: 10.1002/ijc.28667

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  89 in total

1.  STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway.

Authors:  Zhe Liu; Hong Li; Sumeng Fan; Hui Lin; Wenwei Lian
Journal:  Cancer Biol Ther       Date:  2018-11-07       Impact factor: 4.742

2.  Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.

Authors:  Mayuko Kato; Akira Kurozumi; Yusuke Goto; Ryosuke Matsushita; Atsushi Okato; Rika Nishikawa; Ichiro Fukumoto; Keiichi Koshizuka; Tomohiko Ichikawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-06-09       Impact factor: 3.172

3.  Novel long non-coding RNA RP11-119F7.4 as a potential biomarker for the development and progression of gastric cancer.

Authors:  Jingxu Sun; Yongxi Song; Xiaowan Chen; Junhua Zhao; Peng Gao; Xuanzhang Huang; Huimian Xu; Zhenning Wang
Journal:  Oncol Lett       Date:  2015-05-06       Impact factor: 2.967

Review 4.  Molecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer.

Authors:  Mohammadreza Hajjari; Atefeh Khoshnevisan; Young Kee Shin
Journal:  Tumour Biol       Date:  2014-09-30

5.  Long non-coding RNA MEG3 inhibits adipogenesis and promotes osteogenesis of human adipose-derived mesenchymal stem cells via miR-140-5p.

Authors:  Zheng Li; Chanyuan Jin; Si Chen; Yunfei Zheng; Yiping Huang; Lingfei Jia; Wenshu Ge; Yongsheng Zhou
Journal:  Mol Cell Biochem       Date:  2017-04-05       Impact factor: 3.396

6.  MicroRNA-802 plays a tumour suppressive role in tongue squamous cell carcinoma through directly targeting MAP2K4.

Authors:  Xiaozhen Wu; Zuode Gong; Lanying Sun; Long Ma; Qibao Wang
Journal:  Cell Prolif       Date:  2017-03-20       Impact factor: 6.831

7.  Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.

Authors:  Qiang Wang; Xiaoying Wang; Xiufen Tian; Ronghua Tang; Xin Xu
Journal:  J Mol Histol       Date:  2016-01-12       Impact factor: 2.611

8.  MiR-26a inhibits thyroid cancer cell proliferation by targeting ARPP19.

Authors:  Yanping Gong; Wenshuang Wu; Xiuhe Zou; Feng Liu; Tao Wei; Jingqiang Zhu
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

Review 9.  Long non-coding RNAs as novel biomarkers and therapeutic targets in head and neck cancers.

Authors:  Qing-Qing Yang; Yan-Fei Deng
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

10.  Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.

Authors:  Paweena Chunharojrith; Yuki Nakayama; Xiaobing Jiang; Rachel E Kery; Jun Ma; Cristine S De La Hoz Ulloa; Xun Zhang; Yunli Zhou; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2015-08-15       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.